Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: A possible link with thrombosis

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Cugno, Massimo ^a,b   Marzano, Angelo V ^b   Lorini, Maurizio ^a   Carbonelli, Vincenzo ^a   Tedeschi, Alberto ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CARDIOVASCULAR RISK; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EOSINOPHIL; FEMALE; FIBROBLAST; GENE EXPRESSION; HEART INFARCTION; HUMAN; HUMAN CELL; HYPEREOSINOPHILIA; HYPEREOSINOPHILIC SYNDROME; IDIOPATHIC DISEASE; MALE; MIDDLE AGED; MONOCYTE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; THROMBOSIS; WESTERN BLOTTING; BLOOD; CELL LINE; COMPLICATION; GENETICS; HEART MUSCLE ISCHEMIA; METABOLISM;

ADULT; AGED; CELL LINE; ENDOTHELIAL CELLS; EOSINOPHILS; FEMALE; FIBROBLASTS; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; THROMBOPLASTIN; THROMBOSIS;

EID: 84910676732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111862     Document Type: Article

References (32)

1. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, et al. (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38: 709-750.
2. Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 13: 9-22.
3. Kita H (2013) Eosinophils: multifunctional and distinctive properties. Int Arch Allergy Immunol, 161 Suppl 2: 3-9.
4. Blanchard C, Rothenberg ME (2009) Biology of the eosinophil. Adv Immunol 101: 81-121.
5. Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, et al. (2007) Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 109: 995-1002.
6. Roufosse F, Weller PF (2010) Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 126: 39-44.
7. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, et al. (2012) Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 130: 607-612.
8. Chen YY, Khoury P, Ware JM, Holland-Thomas NC, Stoddard JL, et al. (2014) Marked and persistent eosinophilia in the absence of clinical manifestations. J Allergy Clin Immunol 133: 1195-202.
9. Ames PR, Margaglione M, Mackie S, Alves JD (2010) Eosinophilia and thrombophilia in Churg Strauss syndrome: a clinical and pathogenetic overview. Clin Appl Thromb Hemost 16: 628-636.
10. Ogbogu PU, Rosing DR, Horne MK 3rd (2007) Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 27: 457-475.
11. Maino A, Rossio R, Cugno M, Marzano AV, Tedeschi A (2012) Hypereosinophilic syndrome, Churg-Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis. Curr Vasc Pharmacol 10: 670-675.
12. Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS (1993) Eosinophil cationic granule proteins impair thrombomodulin function: a potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest 91: 1721-1730.
13. Marzano AV, Tedeschi A, Rossio R, Fanoni D, Cugno M (2010) Prothrombotic state in Churg-Strauss syndrome: a case report. J Investig Allergol Clin Immunol 20: 616-619.
14. Wang JG, Mahmud SA, Thompson JA, Geng JG, Key NS, et al. (2006) The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood 107: 558-565.
15. Rohrbach MS, Wheatley CL, Slifman NR, Slifman NR, Gleich GJ (1990) Activation of platelets by eosinophil granule proteins. J Exp Med 172: 1271-1274.
16. Gauchat JF, Henchoz S, Fattah D, Mazzei G, Aubry JP, et al. (1995) CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 25: 863-865.
17. Santilli F, Basili S, Ferroni P, Davì G (2007) CD40/CD40L system and vascular disease. Intern Emerg Med 2: 256-268.
18. Ojima-Uchiyama A, Masuzawa Y, Sugiura T, Waku K, Fukuda T (1991) Production of platelet-activating factor by human normodense and hypodense eosinophils. Lipids 26: 1200-1203.
19. Sovershaev MA, Lind KF, Devold H, JØrgensen TØ, Hansen JB, et al. (2008) No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils. J Thromb Haemost 6: 1742-1749.
20. Caraguel CG, Stryhn H, Gagné N, Dohoo IR, Hammell KL (2011) Selection of a cutoff value for real-time polymerase chain reaction results to fit a diagnostic purpose: analytical and epidemiologic approaches. J Vet Diagn Invest 23: 2-15.
21. Zhu L, Gao D, Yang J, Li M (2012) Characterization of the phenotype of high collagen-producing fibroblast clones in systemic sclerosis, using a new modified limiting-dilution method. Clin Exp Dermatol 37: 395-403.
22. Egorina EM, Sovershaev MA, Olsen JO, Østerud B (2008) Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood 111: 1208-1216.
23. Basavaraj MG, Olsen JO, Østerud B, Hansen JB (2012) Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Thromb Res 130: 538-546.
24. Ackerman SJ, Bochner BS (2007) Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Immunol Allergy Clin North Am 27: 357-375.
25. Asero R, Tedeschi A, Coppola R, Griffini S, Paparella P, et al. (2007) Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 119: 705-710.
26. Cugno M, Marzano AV, Tedeschi A, Fanoni D, et al. (2009) Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Immunol 148: 170-174.
27. Marzano AV, Tedeschi A, Fanoni D, Bonanni E, Venegoni L, et al. (2009) Activation of blood coagulation in bullous pemphigoid: role of eosinophils and local and systemic implications. Br J Dermatol 160: 266-272.
28. Marzano AV, Tedeschi A, Berti E, Fanoni D, Crosti C, et al. (2011) Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases. Clin Exp Immunol 165: 44-50.
29. Mandal SK, Pendurthi UR, Rao LV (2006) Cellular localization and trafficking of tissue factor. Blood 107: 4746-4753.
30. Peña E, Arderiu G, Badimon L (2012) Subcellular localization of tissue factor and human coronary artery smooth muscle cell migration. J Thromb Haemost 10: 2373-2382.
31. Langan SM, Hubbard R, Fleming K, West J (2009) A population-based study of acute medical conditions associated with bullous pemphigoid. Br J Dermatol 161: 1149-1152.
32. Yang YW, Chen YH, Xirasagar S, Lin HC (2011) Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke 42: 319-323.